Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 10/2015

01-09-2015 | Original Article

Test–retest reproducibility of the metabotropic glutamate receptor 5 ligand [18F]FPEB with bolus plus constant infusion in humans

Authors: Eunkyung Park, Jenna M. Sullivan, Beata Planeta, Jean-Dominique Gallezot, Keunpoong Lim, Shu-Fei Lin, Jim Ropchan, Timothy J. McCarthy, Yu-Shin Ding, Evan D. Morris, Wendol A. Williams, Yiyun Huang, Richard E. Carson

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2015

Login to get access

Abstract

Purpose

[18F]FPEB is a promising PET radioligand for the metabotropic glutamate receptor 5 (mGluR5), a potential target for the treatment of neuropsychiatric diseases. The purpose of this study was to evaluate the test–retest reproducibility of [18F]FPEB in the human brain.

Methods

Seven healthy male subjects were scanned twice, 3 – 11 weeks apart. Dynamic data were acquired using bolus plus infusion of 162 ± 32 MBq [18F]FPEB. Four methods were used to estimate volume of distribution (V T): equilibrium analysis (EQ) using arterial (EQA) or venous input data (EQV), MA1, and a two-tissue compartment model (2 T). Binding potential (BP ND) was also estimated using cerebellar white matter (CWM) or gray matter (CGM) as the reference region using EQ, 2 T and MA1. Absolute test–retest variability (aTRV) of V T and BP ND were calculated for each method. Venous blood measurements (C V) were compared with arterial input (C A) to examine their usability in EQ analysis.

Results

Regional V T estimated by the four methods displayed a high degree of agreement (r 2 ranging from 0.83 to 0.99 among the methods), although EQA and EQV overestimated V T by a mean of 9 % and 7 %, respectively, compared to 2 T. Mean values of aTRV of V T were 11 % by EQA, 12 % by EQV, 14 % by MA1 and 14 % by 2 T. Regional BP ND also agreed well among the methods and mean aTRV of BP ND was 8 – 12 % (CWM) and 7 – 9 % (CGM). Venous and arterial blood concentrations of [18F]FPEB were well matched during equilibrium (C V = 1.01 · C A, r 2 = 0.95).

Conclusion

[18F]FPEB binding shows good TRV with minor differences among analysis methods. Venous blood can be used as an alternative for input function measurement instead of arterial blood in EQ analysis. Thus, [18F]FPEB is an excellent PET imaging tracer for mGluR5 in humans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130:1007S–15S.PubMed Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130:1007S–15S.PubMed
2.
go back to reference Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res. 2003;140:1–47.PubMedCrossRef Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res. 2003;140:1–47.PubMedCrossRef
3.
go back to reference Fitzjohn SM, Bashir ZI. Metabotropic glutamate receptor-dependent synaptic plasticity. In: Gereau RW, Swanson GT, editors. The receptors: the glutamate receptors. Totowa: Humana Press; 2008. p. 509–28.CrossRef Fitzjohn SM, Bashir ZI. Metabotropic glutamate receptor-dependent synaptic plasticity. In: Gereau RW, Swanson GT, editors. The receptors: the glutamate receptors. Totowa: Humana Press; 2008. p. 509–28.CrossRef
7.
go back to reference Bird MK, Lawrence AJ. Group I metabotropic glutamate receptors: involvement in drug-seeking and drug-induced plasticity. Curr Mol Pharmacol. 2009;2:83–94.PubMedCrossRef Bird MK, Lawrence AJ. Group I metabotropic glutamate receptors: involvement in drug-seeking and drug-induced plasticity. Curr Mol Pharmacol. 2009;2:83–94.PubMedCrossRef
8.
go back to reference Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci. 1996;8:1488–500.PubMedCrossRef Lujan R, Nusser Z, Roberts JD, Shigemoto R, Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci. 1996;8:1488–500.PubMedCrossRef
9.
go back to reference De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci. 2001;22:114–20.PubMedCrossRef De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci. 2001;22:114–20.PubMedCrossRef
10.
go back to reference Patel S, Ndubizu O, Hamill T, Chaudhary A, Burns HD, Hargreaves R, et al. Screening cascade and development of potential positron emission tomography radiotracers for mGluR5: in vitro and in vivo characterization. Mol Imaging Biol. 2005;7:314–23. doi:10.1007/s11307-005-0005-4.PubMedCrossRef Patel S, Ndubizu O, Hamill T, Chaudhary A, Burns HD, Hargreaves R, et al. Screening cascade and development of potential positron emission tomography radiotracers for mGluR5: in vitro and in vivo characterization. Mol Imaging Biol. 2005;7:314–23. doi:10.​1007/​s11307-005-0005-4.PubMedCrossRef
11.
go back to reference Wang JQ, Tueckmantel W, Zhu A, Pellegrino D, Brownell AL. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse. 2007;61:951–61. doi:10.1002/syn.20445.PubMedCrossRef Wang JQ, Tueckmantel W, Zhu A, Pellegrino D, Brownell AL. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse. 2007;61:951–61. doi:10.​1002/​syn.​20445.PubMedCrossRef
12.
go back to reference First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). Washington: American Psychiatric Press; 1996. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). Washington: American Psychiatric Press; 1996.
13.
go back to reference Lim K, Labaree D, Li S, Huang Y. Preparation of the metabotropic glutamate receptor 5 (mGluR5) PET tracer [(18)F]FPEB for human use: an automated radiosynthesis and a novel one-pot synthesis of its radiolabeling precursor. Appl Radiat Isot. 2014;94C:349–54. doi:10.1016/j.apradiso.2014.09.006.CrossRef Lim K, Labaree D, Li S, Huang Y. Preparation of the metabotropic glutamate receptor 5 (mGluR5) PET tracer [(18)F]FPEB for human use: an automated radiosynthesis and a novel one-pot synthesis of its radiolabeling precursor. Appl Radiat Isot. 2014;94C:349–54. doi:10.​1016/​j.​apradiso.​2014.​09.​006.CrossRef
14.
15.
go back to reference Carson RE, Barker WC, Liow JS, Johnson CA. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. IEEE Nucl Sci Symp Conf Rec. 2003;5:3281–5 Carson RE, Barker WC, Liow JS, Johnson CA. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. IEEE Nucl Sci Symp Conf Rec. 2003;5:3281–5
16.
go back to reference Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC, et al. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24–42. doi:10.1038/jcbfm.1993.6.PubMedCrossRef Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC, et al. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24–42. doi:10.​1038/​jcbfm.​1993.​6.PubMedCrossRef
20.
go back to reference DeLorenzo C, Milak MS, Brennan KG, Kumar JS, Mann JJ, Parsey RV. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging. 2011;38:1083–94. doi:10.1007/s00259-010-1723-7.PubMedCentralPubMedCrossRef DeLorenzo C, Milak MS, Brennan KG, Kumar JS, Mann JJ, Parsey RV. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging. 2011;38:1083–94. doi:10.​1007/​s00259-010-1723-7.PubMedCentralPubMedCrossRef
21.
go back to reference Wong DF, Waterhouse R, Kuwabara H, Kim J, Brasic JR, Chamroonrat W, et al. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J Nucl Med. 2013;54:388–96. doi:10.2967/jnumed.112.107995.PubMedCrossRef Wong DF, Waterhouse R, Kuwabara H, Kim J, Brasic JR, Chamroonrat W, et al. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J Nucl Med. 2013;54:388–96. doi:10.​2967/​jnumed.​112.​107995.PubMedCrossRef
22.
go back to reference Kuwabara H, Chamroonrat W, Mathews W, Waterhouse R, Brasic J, Guevara MR, et al. Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain. J Nucl Med. 2011;52 Suppl 1:390. Kuwabara H, Chamroonrat W, Mathews W, Waterhouse R, Brasic J, Guevara MR, et al. Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain. J Nucl Med. 2011;52 Suppl 1:390.
24.
27.
go back to reference DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, et al. In vivo ketamine-induced changes in [11C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biol Psychiatry. 2015;77:266–75. doi:10.1016/j.biopsych.2014.06.024. DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, et al. In vivo ketamine-induced changes in [11C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biol Psychiatry. 2015;77:266–75. doi:10.​1016/​j.​biopsych.​2014.​06.​024.
28.
go back to reference Kagedal M, Cselenyi Z, Nyberg S, Raboisson P, Stahle L, Stenkrona P, et al. A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 – estimating occupancy in the absence of a reference region. Neuroimage. 2013;82:160–9. doi:10.1016/j.neuroimage.2013.05.006.PubMedCrossRef Kagedal M, Cselenyi Z, Nyberg S, Raboisson P, Stahle L, Stenkrona P, et al. A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 – estimating occupancy in the absence of a reference region. Neuroimage. 2013;82:160–9. doi:10.​1016/​j.​neuroimage.​2013.​05.​006.PubMedCrossRef
Metadata
Title
Test–retest reproducibility of the metabotropic glutamate receptor 5 ligand [18F]FPEB with bolus plus constant infusion in humans
Authors
Eunkyung Park
Jenna M. Sullivan
Beata Planeta
Jean-Dominique Gallezot
Keunpoong Lim
Shu-Fei Lin
Jim Ropchan
Timothy J. McCarthy
Yu-Shin Ding
Evan D. Morris
Wendol A. Williams
Yiyun Huang
Richard E. Carson
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2015
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3094-6

Other articles of this Issue 10/2015

European Journal of Nuclear Medicine and Molecular Imaging 10/2015 Go to the issue